COVAXIN, India’s first vaccine candidate against the COVID-19 gets nod from Drugs Controller General of India (DCGI) for human trials.
The post India’s first COVID-19 vaccine ‘COVAXIN’ gets DCGI nod for human trials appeared first on BioTech Times.
About the Author: Biotech Today
You might like
How to Spend Your Biotech Startup’s Money
11 hours ago
0 Likes
0
You Need to Reach Market Readiness? What Now?
6 days ago
2 Likes
7